Cyberounds Logo
July 29, 2010 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Dendritic Cell Immunotherapy
CME credit is no longer available for this conference.
Woondong Jeong, M.D., Brier Rolando, M.D., and Robert G. Lerner, M.D.

Woondong Jeong is a hematology/oncology fellow, Brier Rolando is an internal medicine resident and Robert G. Lerner is Professor of Medicine, all at New York Medical College.

Drs. Jeong, Rolando and Lerner report no conflicts of interest.


Release Date: 11/22/2005
Termination Date: 11/22/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, the participant should be able to:
  • Describe the roles of dendritic cells in immune system
  • Discuss the design and clinical use of dendritic cell vaccine immunotherapy
  • Discuss the human body's immune response to dendritic cell vaccine.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity